LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

Kodu・Aktsiate loetelu・Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc

Avatud

SektorTervishoid

42.54 -0.93

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

42.15

Max

43.61

Põhinäitajad
By Trading Economics
Sissetulek	-14M -105M
Kasumimarginaal	-867.293
Töötajad	316
EBITDA	-15M -104M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+29.9% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-13M 3.3B
Eelmine avamishind	43.47
Eelmine sulgemishind	42.54

Uudiste sentiment

By Acuity

50%

162 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

34.81 / 38.24 Toetus ja vastupanu

Xenon Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. märts 2026, 23:39 UTC

Kuumad aktsiad

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4. märts 2026, 23:20 UTC

Tulu

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4. märts 2026, 21:43 UTC

Tulu

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4. märts 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

4. märts 2026, 23:33 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4. märts 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4. märts 2026, 22:30 UTC

Tulu

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4. märts 2026, 22:30 UTC

Tulu

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4. märts 2026, 22:30 UTC

Tulu

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4. märts 2026, 22:13 UTC

Tulu

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4. märts 2026, 22:13 UTC

Tulu

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4. märts 2026, 22:13 UTC

Tulu

Vermilion Energy 4Q EPS C$2.86 >VET

4. märts 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

4. märts 2026, 21:53 UTC

Tulu

Lithium Americas 4Q Rev $66.8M >LAC

4. märts 2026, 21:53 UTC

Tulu

Lithium Americas 4Q Loss/Shr 52c >LAC

4. märts 2026, 21:52 UTC

Tulu

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4. märts 2026, 21:50 UTC

Tulu

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4. märts 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. märts 2026, 21:48 UTC

Tulu

Webull 4Q Rev $165.2M >BULL

4. märts 2026, 21:48 UTC

Tulu

Webull 4Q EPS 1c >BULL

4. märts 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. märts 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4. märts 2026, 21:40 UTC

Tulu

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4. märts 2026, 21:36 UTC

Uudisväärsed sündmused

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4. märts 2026, 21:27 UTC

Tulu

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4. märts 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4. märts 2026, 21:16 UTC

Tulu

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4. märts 2026, 21:15 UTC

Tulu

Broadcom 1Q EPS $1.50 >AVGO

4. märts 2026, 21:15 UTC

Tulu

Broadcom 1Q Net $7.35B >AVGO

4. märts 2026, 21:15 UTC

Tulu

Broadcom 1Q Rev $19.31B >AVGO

Võrdlus sarnastega

Hinnamuutus

Xenon Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

29.9% tõus

12 kuu keskmine prognoos

Keskmine 55.92 USD 29.9%

Kõrge 66 USD

Madal 44 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Xenon Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

15 ratings

Osta

Hoia

Müü

Põhineb 15 analüütiku instrumendi Xenon Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

34.81 / 38.24Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

162 / 351 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.